
1. mol biochem parasitol. 2012 aug;184(2):71-81. doi:
10.1016/j.molbiopara.2012.04.009. epub 2012 may 8.

biochemical molecular characterization pyrimidine biosynthetic enzyme 
dihydroorotate dehydrogenase toxoplasma gondii.

hortua triana ma(1), huynh mh, garavito mf, fox ba, bzik dj, carruthers vb,
löffler m, zimmermann bh.

author information: 
(1)departamento de ciencias biologicas, universidad de los andes, carrera 1, no. 
18a-10, bogotá, colombia.

the pyrimidine biosynthesis pathway protozoan pathogen toxoplasma gondii
is essential parasite growth infection. investigate properties 
of dihydroorotate dehydrogenase (tgdhod), fourth enzyme t. gondii
pyrimidine pathway, expressed purified recombinant tgdhod. tgdhod
exhibited specific activity 84u/mg, k(cat) 89s(-1), k(m)=60μm for
l-dihydroorotate, k(m)=29μm decylubiquinone (q(d)). quinones lacking or
having short isoprenoid side chains yielded lower k(cat)s q(d). expected,
fumarate poor electron acceptor family 2 dhod. ic(50)s
determined a77-1726, active derivative human dhod inhibitor
leflunomide, related compounds md249 md209 were, 91μm, 96μm, 60μm,
respectively. enzyme significantly affected brequinar ttfa,
known inhibitors human dhod, atovaquone. dsm190, known inhibitor of
plasmodium falciparum dhod, poor inhibitor tgdhod. tgdhod exhibits a
lengthy 157-residue n-terminal extension, consistent potential organellar 
targeting signal. constructed c-terminally c-myc tagged tgdhods examine
subcellular localization tgdhod transgenic parasites expressing tagged 
protein. using exogenous endogenous expression strategies, anti-myc
fluorescence signal colocalized antibodies mitochondrial marker 
atpase. findings demonstrate tgdhod associated parasite's 
mitochondrion, revealing organelle site orotate production t.
gondii. tgdhod gene appears essential gene tagging was
successful tgdhod gene locus, attempts delete tgdhod gene 
successful ku80 background. collectively, study suggests tgdhod
is excellent target development anti-toxoplasma drugs.

copyright © 2012 elsevier b.v. rights reserved.

doi: 10.1016/j.molbiopara.2012.04.009 
pmcid: pmc3855825
pmid: 22580100  [indexed medline]

